The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
Vol. 2, No. 3/4, SPECIAL ISSUE: THE QUALITY OF HEALTH CARE: TRANSACTIONS OF THE 7TH INTERNATIONAL CONGRESS OF THE INTERNATIONAL SOCIETY FOR QUALITY ASSURANCE (1990), pp. 207-212 (6 pages) The use of ...
Plasmodium vivax is the most common parasite that causes malaria in Asia and South America. It preferentially infects an immature red blood cell that accounts for only 1–2% of circulating blood. The ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
Every day, thousands of Indonesians donate blood and plasma, often unaware of the complex scientific and safety-driven processes that transform a single donation into life-saving therapies. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results